Operating Income for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's current operating income (TTM) is -$3.07B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
-$3.07B
YoY change
-22.1%
5Y CAGR
N/A
Peak year (2021)
$13.30B
Cumulative operating income
$9.19B
Operating Income history chart for Moderna (MRNA) from 2016 to 2025
Operating Income history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | -$3.07B | -22.1% | ||
| 2024 | -$3.94B | -6.9% | ||
| 2023 | -$4.24B | -145.0% | ||
| 2022 | $9.42B | -29.2% | ||
| 2021 | $13.30B | -1842.3% | ||
| 2020 | -$763.14M | +39.8% | ||
| 2019 | -$545.72M | +16.4% | ||
| 2018 | -$468.87M | +74.1% | ||
| 2017 | -$269.36M | +20.4% | ||
| 2016 | -$223.77M | — |
Operating Income values are taken from Moderna's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Moderna (MRNA) reported operating income of -$3.07B – declined 22.1% year-over-year.
Between 2021 and 2025, Moderna operating income plunged 123.1%, falling from $13.30B to -$3.07B.
The dataset's maximum operating income sits at $13.30B (2021); the minimum reading of -$4.24B dates to 2023.
Moderna (MRNA) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $22.84B.
Moderna Operating Income by Year
Moderna Operating Income 2025: -$3.07B
Moderna operating income in 2025 was -$3.07B, declined 22.1% below 2024.
Moderna Operating Income 2024: -$3.94B
Moderna operating income in 2024 was -$3.94B, declined 6.9% below 2023.
Moderna Operating Income 2023: -$4.24B
Moderna operating income in 2023 was -$4.24B, plunged 145.0% below 2022. This figure represents the lowest annual value in the available history.
Moderna Operating Income 2022: $9.42B
Moderna operating income in 2022 was $9.42B, declined 29.2% below 2021.
Moderna Operating Income 2021: $13.30B
Moderna operating income in 2021 was $13.30B.
See more financial history for Moderna (MRNA).
Sector peers — Operating Income
Companies in the same sector as Moderna, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Moderna's operating income?
- Latest reported operating income for Moderna (MRNA) is -$3.07B (period ending December 31, 2025).
How has Moderna operating income changed year-over-year?
- Moderna (MRNA) operating income changed -22.1% year-over-year on the latest annual filing.
When did Moderna operating income hit its highest annual value?
- Moderna operating income reached its highest annual value of $13.30B in 2021.
What was Moderna operating income in 2024?
- Moderna (MRNA) operating income in 2024 was -$3.94B.
What was Moderna operating income in 2025?
- Moderna (MRNA) operating income in 2025 was -$3.07B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.